Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Ampio Pharmaceuticals, Inc. stock logo
AMPE
Ampio Pharmaceuticals
$0.29
$1.28
$0.14
$8.30
$326K1.95146,140 shs8,022 shs
LifeVantage Co. stock logo
LFVN
LifeVantage
$6.17
-3.7%
$6.59
$3.04
$8.69
$79.40M0.7834,696 shs18,252 shs
Ritter Pharmaceuticals Inc stock logo
RTTR
Ritter Pharmaceuticals
$0.31
-3.1%
$2.99
$0.15
$1.27
$14.26M-0.4314.23 million shs24,212 shs
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Ampio Pharmaceuticals, Inc. stock logo
AMPE
Ampio Pharmaceuticals
-16.13%+14.40%-82.98%-82.35%-93.26%
LifeVantage Co. stock logo
LFVN
LifeVantage
-3.67%-6.52%-1.59%+7.12%+83.23%
Ritter Pharmaceuticals Inc stock logo
RTTR
Ritter Pharmaceuticals
-1.94%+3.87%-20.59%-37.02%-65.29%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Ampio Pharmaceuticals, Inc. stock logo
AMPE
Ampio Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
LifeVantage Co. stock logo
LFVN
LifeVantage
2.9806 of 5 stars
0.05.01.72.73.11.71.3
Ritter Pharmaceuticals Inc stock logo
RTTR
Ritter Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Ampio Pharmaceuticals, Inc. stock logo
AMPE
Ampio Pharmaceuticals
N/AN/AN/AN/A
LifeVantage Co. stock logo
LFVN
LifeVantage
N/AN/AN/AN/A
Ritter Pharmaceuticals Inc stock logo
RTTR
Ritter Pharmaceuticals
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Ampio Pharmaceuticals, Inc. stock logo
AMPE
Ampio Pharmaceuticals
N/AN/AN/AN/A$4.04 per shareN/A
LifeVantage Co. stock logo
LFVN
LifeVantage
$210.95M0.38$0.53 per share11.67$2.71 per share2.28
Ritter Pharmaceuticals Inc stock logo
RTTR
Ritter Pharmaceuticals
N/AN/AN/AN/A$0.10 per shareN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Ampio Pharmaceuticals, Inc. stock logo
AMPE
Ampio Pharmaceuticals
-$8.63M-$11.01N/AN/AN/A-149.00%-103.79%5/13/2024 (Estimated)
LifeVantage Co. stock logo
LFVN
LifeVantage
$2.54M$0.2326.83N/A1.40%19.96%9.48%5/2/2024 (Confirmed)
Ritter Pharmaceuticals Inc stock logo
RTTR
Ritter Pharmaceuticals
-$10.13MN/AN/AN/AN/AN/A-162.05%N/A

Latest RTTR, LFVN, and AMPE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/2/2024N/A
LifeVantage Co. stock logo
LFVN
LifeVantage
N/AN/AN/AN/AN/AN/A  
3/27/2024Q4 2023
Ampio Pharmaceuticals, Inc. stock logo
AMPE
Ampio Pharmaceuticals
N/A-$2.48-$2.48-$2.48N/AN/A
1/30/2024Q2 2024
LifeVantage Co. stock logo
LFVN
LifeVantage
N/A$0.10+$0.10$0.25N/A$51.62 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Ampio Pharmaceuticals, Inc. stock logo
AMPE
Ampio Pharmaceuticals
N/AN/AN/AN/AN/A
LifeVantage Co. stock logo
LFVN
LifeVantage
$0.142.27%N/A60.87%1 Years
Ritter Pharmaceuticals Inc stock logo
RTTR
Ritter Pharmaceuticals
N/AN/AN/AN/AN/A

Latest RTTR, LFVN, and AMPE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
1/25/2024
LifeVantage Co. stock logo
LFVN
LifeVantage
Quarterly$0.03502.64%2/29/20243/1/20243/15/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Ampio Pharmaceuticals, Inc. stock logo
AMPE
Ampio Pharmaceuticals
N/A
2.41
2.41
LifeVantage Co. stock logo
LFVN
LifeVantage
N/A
1.68
1.03
Ritter Pharmaceuticals Inc stock logo
RTTR
Ritter Pharmaceuticals
N/A
3.67
3.67

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Ampio Pharmaceuticals, Inc. stock logo
AMPE
Ampio Pharmaceuticals
5.73%
LifeVantage Co. stock logo
LFVN
LifeVantage
35.32%
Ritter Pharmaceuticals Inc stock logo
RTTR
Ritter Pharmaceuticals
0.84%

Insider Ownership

CompanyInsider Ownership
Ampio Pharmaceuticals, Inc. stock logo
AMPE
Ampio Pharmaceuticals
3.30%
LifeVantage Co. stock logo
LFVN
LifeVantage
6.76%
Ritter Pharmaceuticals Inc stock logo
RTTR
Ritter Pharmaceuticals
15.40%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Ampio Pharmaceuticals, Inc. stock logo
AMPE
Ampio Pharmaceuticals
61.14 million1.10 millionNo Data
LifeVantage Co. stock logo
LFVN
LifeVantage
24812.87 million12.00 millionOptionable
Ritter Pharmaceuticals Inc stock logo
RTTR
Ritter Pharmaceuticals
746.15 millionN/ANot Optionable

RTTR, LFVN, and AMPE Headlines

SourceHeadline
Jeff RitterJeff Ritter
si.com - April 19 at 4:08 AM
Dr. John D. RitterDr. John D. Ritter
health.usnews.com - January 24 at 12:59 AM
German chocolate war ends with Ritter Sport victoryGerman chocolate war ends with Ritter Sport victory
politico.eu - October 28 at 1:58 AM
Kristen RitterKristen Ritter
health.usnews.com - September 15 at 6:32 PM
Op-ed column: Sandusky sex charges contrast with setup against Scott RitterOp-ed column: Sandusky sex charges contrast with setup against Scott Ritter
dailygazette.com - July 8 at 10:29 PM
Scott Ritter arrested in Pennsylvania on child sex chargesScott Ritter arrested in Pennsylvania on child sex charges
dailygazette.com - July 8 at 5:29 PM
Dr. Harold K. RitterDr. Harold K. Ritter
health.usnews.com - July 8 at 12:28 PM
Denver Business Journal welcomes new tech reporterDenver Business Journal welcomes new tech reporter
bizjournals.com - July 1 at 3:49 AM
Gary W. Ritter, Ph.D.Gary W. Ritter, Ph.D.
slu.edu - June 16 at 11:16 PM
Jason Ritter and Drew Barrymores raw conversation on her show may matter more than you thinkJason Ritter and Drew Barrymore's raw conversation on her show may matter more than you think
usatoday.com - April 10 at 12:53 PM
Ritter Pharmaceuticals Changing the Game With Lactose Intolerance TreatmentRitter Pharmaceuticals Changing the Game With Lactose Intolerance Treatment
thestreet.com - March 29 at 11:51 PM
Global Microbiome Market Report 2023: Major Players Include MicroBiome Therapeutics, Seres Therapeutics, Enterome Bioscience and Second GenomeGlobal Microbiome Market Report 2023: Major Players Include MicroBiome Therapeutics, Seres Therapeutics, Enterome Bioscience and Second Genome
finance.yahoo.com - March 18 at 2:27 PM
Melanie Lynskeys husband Jason Ritter will join her in Yellowjackets this seasonMelanie Lynskey's husband Jason Ritter will join her in Yellowjackets this season
yahoo.com - January 19 at 10:27 AM
Ritter Public Library in Vermilion adds book clubRitter Public Library in Vermilion adds book club
morningjournal.com - January 15 at 8:09 AM
Microbiome Clinical Trial Pipeline Space Brims with Novel Emerging Therapies with 130+ Key Players Working in the Domain | DelveInsightMicrobiome Clinical Trial Pipeline Space Brims with Novel Emerging Therapies with 130+ Key Players Working in the Domain | DelveInsight
finance.yahoo.com - November 16 at 3:38 AM
Burlington freshman Olivia Ritter hits to pool as Olivia Kraus climbs out of the waterBurlington freshman Olivia Ritter hits to pool as Olivia Kraus climbs out of the water
thehawkeye.com - October 1 at 2:57 PM
Tuesday roundup: Sandy Valley senior golfer Connor Ritter records hole-in-one and sets new school recordTuesday roundup: Sandy Valley senior golfer Connor Ritter records hole-in-one and sets new school record
cantonrep.com - September 11 at 10:23 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Ampio Pharmaceuticals logo

Ampio Pharmaceuticals

NYSE:AMPE
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.
LifeVantage logo

LifeVantage

NASDAQ:LFVN
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. The company also provides anti-aging skin care products, including liquid collagen, facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. In addition, it offers bath and body, and targeted relief products, such as body lotion, body wash, body butter, deodorant, soothing balm, and body rub under the TrueScience brand name. It sells its products through its website and network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. The company was founded in 2003 and is headquartered in Lehi, Utah.
Ritter Pharmaceuticals logo

Ritter Pharmaceuticals

NASDAQ:RTTR
Ritter Pharmaceuticals, Inc. develops and sells novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases. Its lead product candidate is RP-G28, a novel microbiome modulator, which has completed Phase 2b clinical trial for the reduction of symptoms associated with lactose intolerance. The company's product, RP-G28 is designed to stimulate the growth of lactose-metabolizing bacteria in the colon, thereby adapting the gut microbiome to assist in digesting the lactose that reaches the large intestine. The company was formerly known as Ritter Natural Sciences, LLC and changed its name to Ritter Pharmaceuticals, Inc. in September 2008. Ritter Pharmaceuticals, Inc. was founded in 2004 and is headquartered in Los Angeles, California.